Lisi, Lucia
 Distribuzione geografica
Continente #
EU - Europa 3.427
NA - Nord America 3.205
AS - Asia 881
SA - Sud America 179
AF - Africa 12
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.710
Nazione #
US - Stati Uniti d'America 3.167
PL - Polonia 1.237
DE - Germania 731
IT - Italia 484
CN - Cina 320
SE - Svezia 317
SG - Singapore 303
UA - Ucraina 175
BR - Brasile 163
GB - Regno Unito 109
FR - Francia 106
IE - Irlanda 90
IN - India 78
ID - Indonesia 60
FI - Finlandia 59
RU - Federazione Russa 40
VN - Vietnam 26
CA - Canada 23
TR - Turchia 21
BE - Belgio 19
ES - Italia 15
HK - Hong Kong 14
KR - Corea 13
NL - Olanda 13
MX - Messico 10
AT - Austria 8
JP - Giappone 8
IQ - Iraq 7
AR - Argentina 5
CH - Svizzera 5
CL - Cile 5
SA - Arabia Saudita 5
BD - Bangladesh 4
IR - Iran 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CZ - Repubblica Ceca 3
LT - Lituania 3
TH - Thailandia 3
CI - Costa d'Avorio 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 7.710
Città #
Warsaw 1.221
Chandler 441
Ashburn 261
Fairfield 245
Singapore 179
Wilmington 137
Jacksonville 135
Houston 133
Woodbridge 129
Chicago 117
San Mateo 107
Cattolica 98
Seattle 92
Dublin 90
Verona 84
Ann Arbor 82
Cambridge 82
Rome 80
Nanjing 63
Jakarta 59
Los Angeles 58
Milan 52
Dearborn 49
New York 49
Bremen 46
Munich 44
Redwood City 40
Salt Lake City 40
Nürnberg 36
Buffalo 34
Lawrence 33
Boston 31
Nanchang 31
Moscow 26
Beijing 25
Lancaster 24
Princeton 21
Brussels 19
The Dalles 19
Helsinki 18
Dong Ket 17
Hefei 16
Marseille 15
Mountain View 15
Elk Grove Village 14
Kraków 14
London 14
Pune 14
Redmond 14
Frankfurt am Main 13
Hangzhou 13
Phoenix 13
San Diego 13
Seoul 13
Tampa 13
University Park 13
Shanghai 12
Shenyang 12
Changsha 11
Dallas 11
Hong Kong 11
Izmir 11
North Bergen 11
Norwalk 11
Nuremberg 11
Toronto 11
Boardman 10
Falkenstein 10
Fremont 10
Guangzhou 10
Jiaxing 10
Leawood 10
Montesilvano Marina 10
Zhengzhou 10
Busto Arsizio 9
Belo Horizonte 8
Hebei 8
Hyderabad 8
Paris 8
Kunming 7
Miami 7
Rio de Janeiro 7
Andover 6
Detroit 6
Falls Church 6
Monmouth Junction 6
Nanning 6
Salvador 6
Corchiano 5
Düsseldorf 5
Gurgaon 5
Manchester 5
Philadelphia 5
Porto Alegre 5
Santa Clara 5
Stockholm 5
São Paulo 5
Brooklyn 4
Chiswick 4
Fondi 4
Totale 5.101
Nome #
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 382
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 368
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 364
mTOR kinase: a possible pharmacological target in the management of chronic pain 362
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 332
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 318
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 315
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 314
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 285
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis 170
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 151
Antiretrovirals inhibit arginase in human microglia 149
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis 148
Variability of raltegravir plasma levels in the clinical setting 141
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 139
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 131
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 127
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 121
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 121
Pro-inflammatory activation of a new immortalized human microglia cell line 118
Antiretrovirals inhibit arginase in human microglia 116
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 115
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 111
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 110
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 104
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 102
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 102
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 100
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 97
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 96
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 92
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 91
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 91
Exploiting microglial functions for the treatment of glioblastoma 90
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 88
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 87
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 86
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 85
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 85
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 83
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 82
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 82
Exploiting Microglial Functions for the Treatment of Glioblastoma 79
Interactions between Integrase Inhibitors and human Arginase 1 77
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 77
DNA inhibitors for the treatment of brain tumors 73
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 72
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 71
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 71
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 71
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 68
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 66
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 66
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids 63
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 60
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples 60
The effects of painless nerve growth factor on human microglia polarization 52
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy 37
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19 34
The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review 32
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib 27
A topographic approach to the markers of macrophage/microglia and other cell types in high grade glioma 11
Glioma-Associated Microglia Characterization in the Glioblastoma Microenvironment through A ‘Seed-and Soil’ Approach: A Systematic Review 11
Totale 7.829
Categoria #
all - tutte 28.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 0 0 0 0 0 0 0 69
2020/2021907 58 100 25 74 115 64 147 20 105 65 97 37
2021/2022755 74 56 13 29 66 30 11 97 30 60 170 119
2022/20231.127 128 163 107 188 76 137 25 95 137 20 27 24
2023/2024607 35 146 27 53 27 68 65 33 9 13 52 79
2024/20251.408 23 34 102 53 88 58 24 61 189 120 596 60
Totale 7.829